FDA Inspection 569265 — US Oncology, Inc. IRB
The FDA completed an inspection of US Oncology, Inc. IRB on March 12, 2009 in The Woodlands, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 12, 2009
- Fiscal Year
- 2009
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- The Woodlands, TX (United States)
Additional Details
IRB